FDA Generics Director’s Departure Shows Why Chemistry Matters
Executive Summary
Another outside candidate is expected to eventually take over for the departing director Gregory Geba, and while the Office of Generic Drugs can run smoothly without a permanent leader for now, it cannot do so forever.
You may also be interested in...
The Risk-Reward Of US FDA Leadership Running Offices Below Them
CBER’s Celia Witten is the latest senior executive to run an office within the center during a leadership transition, a move that can help achieve specific goals, but also create tension.
FDA Talent Hunt: Better To Recruit From Academia Than Industry?
CDER Oncology office head Richard Pazdur says making FDA more academic could help with retention. In addition to having fewer staff than needed to complete its work, FDA’s hiring problem makes it difficult for the agency to stay abreast of new scientific discoveries and technology.
FDA Talent Hunt: Better To Recruit From Academia Than Industry?
CDER Oncology office head Richard Pazdur says making FDA more academic could help with retention. In addition to fewer staff than needed to complete its work, FDA’s hiring problem makes it more difficult for the agency to stay abreast of new scientific discoveries and technology.